M. Gross et al., INTEREST AMONG GAY BISEXUAL MEN IN GREATER BOSTON IN PARTICIPATING INCLINICAL-TRIALS OF PREVENTIVE HIV VACCINES/, Journal of acquired immune deficiency syndromes and human retrovirology, 12(4), 1996, pp. 406-412
To estimate interest in HIV preventive vaccine trials, we administered
questionnaries to two otherwise demographically similar cohorts of ol
der (mean 40 years) and younger (mean 23 years) gay men in Boston. Que
stionnaire responses were linked to concurrent behavioral and demograp
hic data. Univariate analyses, performed separately for older and youn
ger cohorts, identified factors that distinguished participants who we
re ''very interested'' from those who were ''not at all interested.''
Multivariate logistic regression analyses were used to adjust for conf
ounding. Among all 630 participants, 215 (34%) were ''not at all'' int
erested in participating, 306 (49%) were ''some-what'' interested, and
102 (16%) were ''very interested. Older men were significantly more l
ikely than younger men to be ''very'' interested and less likely to be
''not at all interested.'' Among both older and younger men, perceive
d peer willingness to enroll in vaccine trials predicted interest afte
r adjusting for confounding. Among older men, optimism about success i
n vaccine development also predicted interest. In the younger cohort,
men recruited in community settings (e.g, bars. nightclubs) were more
interested in vaccine trial participation than were those recruited by
outreach workers and word of mouth on college campuses. Vaccine-induc
ed seroconversion evoked significant concern.